Colombia Archives - Mother on the Tower Blog

UK AHVID responds to EMA conclusion that HPV vaccines do not cause POTS or CRPS#android#iPad#retweet

November 13, 2015November 6, 2015 jv Leave a comment

By Steve Hinks email steve@hinksfamily.co.uk)

The European Medicines Agency has today released the Pharmacovigilance Risk Assessment Committee’s conclusion of their review of HPV vaccines in relation to two serious neurological conditions, Postural Orthostatic Tachycardia Syndrome (POTS) and Complex Region Pain Syndrome (CRPS). The PRAC assessment concluded that the available evidence does not support that CRPS and POTS are caused by HPV vaccines.

The UK Association of HPV Vaccine Injured Daughters (AHVID) is extremely disappointed by the committee’s findings and concerned by the lack of transparency and opportunity to scrutinize the evidence considered by the PRAC before the Committee for Medicinal Products for Human Use (CHMP) adopts the committee’s findings.

Freda Birrell, Chair of AHVID said:

“Groups across Europe representing families of girls suffering new health conditions following HPV vaccination will naturally be very disappointed with this investigation and we are particularly concerned that the evidence considered by the PRAC will not be made available for scrutiny until after CHMP has reviewed the PRAC Assessment and adopted the decision. We have even been denied a request to know which experts submitted evidence. This shroud of secrecy is very concerning – something is leaving these girls seriously ill! We are however, very encouraged by the recent award of research funding from the Danish health authorities to a Danish team of doctors, to research adverse reactions to the HPV vaccination, and we await the results of that research with anticipation, particularly in light of recent reports from Denmark estimating 1 in 400 girls are suffering serious adverse reactions to the HPV vaccination.”

AHVID recently conducted a survey of members for information to submit to the EMA review. The findings from nearly 100 members highlighted massive under-reporting of adverse reactions by health professionals, a failure of health professionals to recognize and acknowledge adverse reactions and the difficulties experienced getting a POTS diagnosis, with most girls waiting for more than two years. Shockingly, the survey also found over 90% of respondents were initially told by their doctors that their symptoms were psychological.

The PRAC appear to have based their decision on their statement that the available estimates suggest natural rates of both POTS and CRPS to be around 150 girls per million in the age range of 10 to 19. AHVID are unable to comment on this statement because the request for copies of evidence and reports considered by the Committee have been refused until the Review is finalized, but the group remain convinced the HPV vaccination is resulting in girls developing serious autoimmune and neurological conditions, including POTS and CRPS.

The PRAC makes reference to an overlap of CRPS and POTS symptoms with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and the ‘large published study that showed no link between HPV vaccine and CFS’, which the Committee considered particularly relevant. The study ‘Bivalent HPV vaccine and the risk of fatigue syndromes in girls in the UK’ was undertaken and authored by MHRA scientists, it was looking only at the Cervarix vaccine, used data from the CRPD database which is collected for clinical management, not research, was open to confounding and selection bias and was at the mercy of the accuracy of GPs inputting accurate diagnostic codes. The study would also have been unlikely to have picked out cases of POTS or CRPS and would certainly have missed the many girls with POTS who were initially misdiagnosed with anxiety or psychological conditions.

AHVID will continue to support families with girls suffering new health conditions following HPV vaccination and will continue to fight for better treatment for the affected girls, more transparency and full information about the risks of this vaccination to be made available to parents prior to consent. Their aim is also to ensure the MHRA are held to account and made to follow up all reports of serious adverse reactions, which currently does not happen.

Notes:

AHVID recently conducted a member questionnaire and, so far, has received almost 100 responses. Information for the first 94 responses had been already shared with the EMA. Many of the questionnaire responses leave no doubt whatsoever in our opinion that these vaccines have at least contributed to the girls’ side effects.

AHVID has found that in the first 94 questionnaire submissions:

Yellow Cards have only been submitted by 13 doctors whilst the girls had been seen by a total of approximately 858 doctors. There were also 7 doctors who refused to raise Yellow Cards.
15 of these had reactions after the 1st and/or 2nd dose. They continued to have the 2nd and 3rd doses because the serious side effects were not perceived to be adverse reactions to the vaccine. They had all been told that the vaccine is safe and side-effects are only mild and short term.
27 girls had reactions on the same day as the vaccine, some of them within minutes. A further 22 had reactions within 7 days of vaccination and a further 16 within 30 days. This cannot be a coincidence.
66 girls with previously regular periods developed severe problems, many of them serious. 20 girls with irregular periods developed new problems, many of them serious. At least 4 girls have been diagnosed with polycystic ovaries.
53 girls were found to have vitamin and mineral deficiencies with 33 of these being for vitamin D.
24 have confirmed POTS diagnosis, some took 6 and a half years from vaccination to be diagnosed
37 have not been diagnosed with POTS but have an average of 16 typical POTS symptoms. Some had 33 typical POTS symptoms. 19 were refused POTS assessments.
8 have confirmed diagnosis of CRPS.
76 have not been diagnosed with CRPS but have an average of 5 typical CRPS symptoms. 14 were refused CRPS assessments.

Danish reports highlighting estimates of 1 in 400 girls suffering serious adverse reactions:

For further information about AHVID contact: Freda Birrell (chair) at jeanfreda8@btinternet.com or tel: 07752 945545

This article in it’s entirety, is compliments of Sane Vax

HPV Vaccines: Freda Birrell Addresses Scottish Petitions Committee#android#iPad#retweet

November 4, 2015November 2, 2015 jv Leave a comment

BY ADMIN

I would like to thank the Committee for allowing me to provide additional information relating to my request for ‘A round table discussion to be held at Edinburgh between scientists and medical professionals from both sides of the HPV vaccine safety debate.’ I speak today on behalf of not only the UK Association for HPV Vaccine Injured Daughters who have had their lives turned upside down after HPV vaccine administration, but each of the 2019 people from 55 countries who signed because they are having similar experiences and support open scientific discussions.

Our association was organized at the beginning of this year when it became apparent that we needed to co-ordinate everyone’s individual efforts as a group. Our association represents families from Scotland, England, Wales and Northern Ireland operating under the banner of HPV Vaccine Injured Daughters (AHVID). As a group, we were able to receive greater publicity. The increased awareness caused our membership to grow by leaps and bounds. Our initial group of 60 members has expanded to 208 and rising. Despite the fact that Scotland only accounts for 8% of the UK population; 15% of the association’s members come from Scotland. We don’t know how many others are out there, but for now there appears to be no end in sight.

A senior politician within the Irish Government, Pashal Mooney, gave an impassioned plea to Irish Government officials regarding the Irish HPV vaccination program, lack of informed consent and the devastating effects on young girls around the country. He specifically mentions Irish girls being admitted to psychiatric hospitals following HPV vaccinations.

Japan has rescinded the government recommendation for HPV vaccines and initiated studies to determine whether there is a causal relationship between HPV vaccines and adverse outcomes as well as a 21 year study to determine whether HPV vaccines have an impact on cervical cancer diagnosis rates.

In Denmark, the National Association of HPV Adverse Sufferers is hosting an HPV Vaccine Information Symposium to bring families together with medical professionals, health authorities and legal professionals to explore treatment options and potential legal remedies on October 31^st. Denmark has just recently made the decision to change from Gardasil to Cervarix as the HPV vaccine of choice. 24 Oct 2015, at the urging of Liselott Blixt, Danish politician with a Gardasil injured daughter the Danish government has set aside 7 million kroner to conduct an independent investigation into the HPV vaccine and its side effects.

Our association is in the process of compiling information to submit to the EMA for consideration during their safety assessment of HPV vaccines. Of the 88 family reports analysed to date: 68% reported their daughters experienced health problems serious enough to interfere with their education; 24% reported symptoms so severe their daughter could no longer participate in educational activities; 70% required help with daily care; and a full 91% reported being told their daughters’ medical conditions were psychological in origin.

Psychological in origin? Interesting to note that national health authorities in Denmark, Norway, Japan, France, Spain, Colombia, Ireland, and many other countries have led doctors and other vaccine administrators to believe that any new medical conditions experienced after HPV vaccine administration are most likely psychosomatic. Consequently, when the average medical health professional is faced with a patient exhibiting symptoms they have never seen before; symptoms which do not fit neatly into any current diagnostic criteria, the natural assumption is psychological problems as have been experienced by many UK families.

So, I put forth these facts for your consideration:

According to Merck’s Gardasil 9 package insert, 3.3% of participants who were given Gardasil during the most recent clinical trials “experienced new medical conditions potentially indicative of autoimmune disorders.” (3,300/100,000 recipients)
According to a press release from Sanofi-Pasteur MSD dated June 17, 2015, 183 million doses of Gardasil have been distributed worldwide.
Using Merck’s own clinical trial percentage, this means there could be as many as 6,039,000 girls around the world suffering autoimmune conditions which could very well influence their health for the rest of their lives.
According to the World Cancer Research Foundation, there were 528,000 cases of cervical cancer diagnosed worldwide in 2012.

Is this worth the risk? I am very much aware HPV vaccines are a controversial issue and that this information puts Scotland at a cross-roads with a difficult decision to make.

Do we accept what the manufacturer and their list of experts are saying and assume HPV vaccines are safe and effective and there just happens to be an epidemic of psychosomatic disorders spreading round the world affecting certain young people who have one thing in common, they were injected with HPV vaccines?

Or, do we listen to experts from both sides, try to discover exactly what the situation is and make every effort we can to get the problem solved?

Do we sweep all of these families under the proverbial ‘psychological disorder’ carpet and ignore their misery; or do we treat them with the dignity and respect they deserve by using every means at our disposal to identify those at risk of serious adverse reactions and develop successful treatment protocols for those already suffering?

Please, demonstrate to the world that Scotland is still a country that does not ignore the suffering of innocents.

Show the world Scotland is not afraid to hold open, honest scientific discussions no matter how controversial the subject might be.

Witness Freda’s presentation here, beginning at the 1:00:00 mark.

View petition documents, including supporting evidence from medical and scientific professionals here.

Read this presentation in Spanish here.

References:

This article in it’s entirety, is compliments of www.SaneVax.org

Court told of ‘horrendous adverse effects’ of HPV vaccine#android#iPad#retweet

November 3, 2015November 3, 2015 jv Leave a comment

by Mary Carolan

A mother who claims her daughter suffered “horrendous adverse effects” after receiving the HPV vaccine against cervical cancer has brought legal proceedings.

Fiona Kirby, Kilbeggan, Co Westmeath, is a member of a parents support group, REGRET (Reaction and Effects of Gardasil Resulting in Extreme Trauma), for those who claim their teenage girls became ill after getting the vaccine.

Ms Kirby, a nurse, is seeking a High Court order for the withdrawal of the license given for the Gardasil HPV vaccine, currently being offered to the parents of 11-16 year old girls as a possible cervical cancer preventative.

An order restraining the Health Products Regulatory Authority (HPRA), which monitors health products in Ireland, proceeding with use of Gardasil in any vaccine programme is also sought.

The vaccine has been offered to teenage girls in Ireland since May 2010 as part of the schools vaccination programme and is recommended by the World Health Organsiation.

The REGRET group…

Continue to the Article Here

http://www.irishtimes.com/

HPV Vaccines: Updates from Central and South America#android#iPad#retweet

June 19, 2015June 19, 2015 jv Leave a comment

By Norma Erickson

Are HPV vaccines the number one cause of coincidence around the globe? Are we facing one of the worst epidemics of mass hysteria the world has ever seen? Apparently, health authorities around the world would like us to believe one of these two scenarios.

Almost without exception, survivors of new medical conditions after the administration of Gardasil or Cervarix are told their problems are coincidental, psychosomatic, mass hysteria, conversion disorder, and so on…ad nauseam. The health authorities in one country (Colombia) even went so far as to attribute new medical conditions after Gardasil to the overuse of Ouija boards.

If all of the above fail, the next step is to try and blame the new symptoms on the parents with phrases like Munchausen by proxy, factitious disorder, fabricated or induced illness, attention seeking, simply out for money, and so on.

The first problem with all of these theories is they are usually put forth after little or no medical investigation. This leaves parents who believed their health authorities and had their daughters injected with the newest miracle vaccine feeling confused, abandoned and betrayed by the very people they trusted to protect their children’s health and well-being.

The second problem with all of these theories is they delay potentially life-saving treatments which could be provided if investigations took place, accurate diagnoses made and treatment protocols designed and implemented.

Read the following updates and ask yourself – What is wrong with this picture?

Colombia: First Reported Fatality after Gardasil

On May 22, 2015 16-year old Karen Durán-Cantor died after complications related to new onset autoimmune disorders believed to have been triggered by two injections of Gardasil, the human papillomavirus vaccine currently being given to school age girls throughout the country.

Karen received her first Gardasil shot at the end of 2013 and the second one a few months later in early 2014. According to her mother, Karen’s hands got swollen almost imediately. She began to experience joint and finger pain that was diagnosed as Juvenile Rheumatoid Arthritis. Despite receiving medical therapy, her disease progressed forcing Karen to stop attending school due to the constant severe pain. Consequently, she was not able to graduate from high school with her classmates.

Karen and her family sought a second opinion in Bogotá’s Clinica Colsubsidio where she was also diagnosed with pleural effusion requiring drainage to help her breathe. By this time, Karen had lost the ability to walk. She could not go to the bathroom or take a shower by herself. She had nearly constant pain on the right side of her body (the side where the Gardasil injection was administered). Karen frequently complained she was short of breath and it was difficult for her to breathe.

Just prior to her death, Karen experienced difficulty breathing and required oxygen. She was referred to La Samaritana Hospital in Bogotá where she was admitted to the Intensive Care Unit where she developed fatal respiratory failure.

These are photos of Karen before and after her Gardasil injections. Please note this dramatic change occured between the end of 2013 and the middle of 2015 – approximately a year-and-a-half.

Despite her personal pain, Karen produced a video to warn others about the possible consequences of using Gardasil shortly before her death.

This is the first documented death after the development of autoimmune disorders following the administration of Gardasil in Colombia.

In addition to the pain and grief this family has already had to endure, they have a long journey ahead of them as they attempt to locate a forensic expert to determine the exact cause of their daughter’s death.

Karen’s family is not alone in Colombia. Hundreds of girls have developed new medical conditions that may have been triggered by Colombia’s recent mandatory HPV vaccination program. The Colombian National Institute of Health did carry out an investigation. The lead investigator was Dr. Fernando De La Hoz, a prominent epidemiologist, who resigned after concluding that the adverse events developed by the girls was a result of mass psychogenic disease.

What is wrong with this picture?

Mexico: Several schools cancel HPV vaccinations

Gardasil was introduced in Mexico in 2008, but only to 125 targeted municipalities with the ”lowest human development index” which were estimated to have the highest incidence of cervical cancer. The quadrivalent HPV vaccine was delivered to these communities via mobile health clinics to girls who were 12-16 years of age using the currently recommended dosing schedule of 0, 2, and 6-months.

In 2009, the program was expanded to include 182 municipalities, still with the ”lowest human development index,” but this time with the first two doses being delivered at 0 and 6 months and the third dose 60 months later (5 years) and the targeted girls being ages 9-12.

Considering the current Supreme Court Case in India, one has to wonder… Were these parents informed of the fact their daughters were participants in a clinical trial to determine appropriate dosing regimens?

Why did both programs target girls in so many locations with the lowest human development index? What was the rate of adverse events among the participants?

In 2011, Mexico’s National Immunization Council approved a nationwide expansion of its HPV vaccination program to include school-based HPV vaccination for all 9-year-old girls.

Two months before leaving office in 2012, Mexican President Felipe Calderon made HPV vaccination mandatory for all 11-12 year old girls.

According to Chapter 4 of the Comprehensive Cervical Cancer Control: A guide to essential practice, published on February 11, 2013 by the World Health organization, Mexico is currently using alternative dosing schedule, which is not approved or recommended by WHO at this time. (verify on page 6)

May 2015, after only 500 doses of Gardasil were administered under this program, the Mexican Social Security Institute (IMSS) had to cancel the HPV immunization program at some schools because parents were refusing to allow their 9-year-old girls to receive the injections.

What is wrong with this picture?

Brazil: Uptake of HPV vaccine drops from 83% to 40%

In 2012, Gardasil sales in Japan generated $140 million. In 2013, the Japanese Health Ministry rescinded its recommendation for the use of HPV vaccines causing Merck to look for replacement markets.

By August of the same year, Brazil had agreed to set aside almost $160 million for the purchase of HPV vaccines for use in 2014.

But, 2014 would not be Brazilian girl’s first exposure to Gardasil. According to an article published in Elselvier’s Trials in Vaccinology in 2013, clinical trials using Gardasil were being conducted in the municipality of Campos dos Goytacazes, Rio de Janeiro, Brazil during 2010, 2011 and 2012.

According to the abstract, the objectives of these trials were:

Assess vaccination coverage in that municipality after adopting several strategies for active search and missed opportunities for vaccination against HPV. Evaluate acceptance for the vaccine and reasons for refusal the HPV vaccine. Evaluate the frequency and occurrence of adverse events to that vaccine. A survey of reduction of genital warts was also conducted.

The paper goes on to state that between September 2010 and December 2012, approximately 90,000 doses of Gardasil were used. This number of doses should have covered 30,000 recipients.

However, the ’evaluation of the frequency and occurrence of adverse events’ consisted of conducting a survey of 1,000 randomly selected teenagers to be followed up on 96 hours after vaccine administration to evaluate safety and tolerability.

The authors stated the results of this survey as follows:

There were observed a total of 430 local and systemic events in 360 subjects (36% of 1000 girls), stratified by each dose received. No serious adverse events or any hospitalization were reported;

96 hours; only four days? Are these people serious? How can the safety and tolerability of any vaccine be accurately assessed only 4 days after administration?

Nevertheless, the authors’ conclusion confidently stated:

According to our results, it seems evident that the good coverage achieved by vaccination against HPV in Campos dos Goytacazes, coupled with no serious adverse events to the vaccine reported throughout the study, point to the feasibility of this vaccination strategy, which can also be used in other municipalities. Taking into account not only the benefits but also the results with regard to the reduction of genital warts, amply demonstrated by international studies [18] and [19], we then seek to suggest the inclusion of HPV vaccination in the Brazilian calendar.

By the end of the same year this study was published, Brazilian health authorities had committed nearly $160 million precious healthcare dollars to the purchase of Gardasil for their 2014 national immunization program.

Between March and May of 2014, 83% of the targeted girls (ages 11-13) in Brazil had received their Gardasil injections. By the end of the year 100% of the targeted 4.9 million girls had been vaccinated.

During the same period (March through May) this year another 4.9 million girls (ages 9-11) were targeted, but only 40.2% of them took the vaccine. Could it be because of stories like these?

What is wrong with this picture?

Part of this article has been translated into French here.

Sources:

This article in it’s entirety, is compliments of www.SaneVax.org

HPV vaccines: Colombian Controversy Continues#android#iPad#follow

April 17, 2015April 16, 2015 jv Leave a comment

By Norma Erickson

On February 16, 2015, Colombia enacted a new law (1751 of 2015) which establishes human health as an autonomous fundamental right. As a fundamental right, it means services promoting health, disease prevention, diagnosis, treatment, recovery, rehabilitation and palliative care should be ensured under the responsibility of State to all people without distinction of any kind. What this means for Colombian survivors of HPV vaccinations remains to be seen.

Theoretically, this new law would guarantee the victims of serious adverse events after HPV vaccines could receive any diagnostic tests and treatments necessary for them to recover their former state of health at the expense of the government regardless of their health insurance status, social standing, or location. This is particularly true since the government mandated the HPV vaccines which have apparently injured so many young women in Colombia.

February 26, 2015, Fernando de la Hoz resigned from his position as Director General of the INS (National Institute of Health). Despite the fact that de la Hoz held this position for just a little over a year, he claims his resignation had nothing to do with the recent controversy over the multitude of serious new medical conditions occurring after Colombia’s recent HPV vaccination program.

Fernando de la Hoz said his resignation was not related to the backlash from parents in Colombia who believe their daughters are survivors of severe adverse reactions to HPV vaccines resulting from the release of a report compiled by the National Institute of Health (INS) which declared the symptoms to be a result of mass psychogenic illness.

Parents March for their Daughters

March 6, 2015, hundreds of parents of girls with new medical conditions occurring after the second dose of Gardasil marched in Carmen de Bolivar to bring attention to the serious health issues their daughters are dealing with.

March 8, 2015, in conjunction with parades celebrating International Women’s Day and the March for Life, parents from Carmen de Bolivar were joined by others marching in Bogota, Cali, Medelin and Sincelejo.

According to Jaun Carlos Jimenez of the Committee of Parents of Girls of Carmen de Bolivar, all marches were focusing on demands for their government health officials to:

Conduct studies to determine the exact cause(s) of the new medical conditions suffered by so many after the administration of HPV vaccines
Provide adequate treatment for the 800 girls known to be affected to date
Suspend the use of HPV vaccines in Colombia until such time as the safety issues are resolved

Parents of affected girls say government health authorities have eliminated any possibility of real diagnoses and treatment for their children by adopting the theory put forth by a Colombian National Institute of Health (INS) study stating that the vaccine has no relation to these diseases and that they are due to mass psychogenesis.

This leaves hundreds of Colombian parents desperate for answers and treatment protocols for their daughters, parents who believe their girls are survivors of adverse reactions to HPV vaccines.

Independent Medical Professionals Agree with Parents

Dr. Yehuda Shoenfeld, arguably the world’s foremost expert on autoimmune disorders, shocked the audience of the III Colombian Symposium on Autoimmunity by stating he would not recommend HPV vaccines for his own daughter.

When asked about the mass psychogenesis theory explaining the new medical conditions occurring in so many Colombian girls shortly after HPV vaccinations, he replied:

Although it is known that there are sometimes panic reactions, especially among women, it is very unlikely that the symtoms presented after receiving the vaccine are due to psychological reasons, expecially if one takes into account what is happening in different parts of the world with the same signs and symptoms.

When we administered HPV vaccines to mice, they had the same symptoms as girls affected. I don’t believe the mice bewitched each other. As with any drug prescriberd to a patient, we must consider whether certain vaccines are needed.

If the negative effects outweigh the benefits, the vaccine should not be prescribed.

For Dr. Shoenfeld, HPV vaccines fall into this category. According to Dr. Shoenfeld, this has been demonstrated in Colombia where hundreds of children are suffering from autoimmune disorders directly caused by the vaccine. Dr. Shoenfeld stated:

If there is a case, or an avalanche of cases, this must be investigated in the proper way. To say it is something psychological or viral is not enough. You need scientists from different disciplines to analyze it.

We believe aluminum is a toxic substance for the brain. It accumulates, continues this for weeks and months. It’s like a Trojan Horse for the brain. Aluminum is a neurotoxin. Experimental research shows clearly that aluminum adjuvants have a potential for inducing serious immunological disorders in humans. In particular, aluminum adjuvants carry a risk for autoimmunity, inflammation of the brain and neurological long-term complications and therefore can have profound and widespread consequences for health.

According to Dr. Juan Manuel Anaya, director of the Center for Autoimmune Diseases, University of Rosario,

The development of autoimmune diseases is an issue of paramount importance when it comes to vaccines.

The trouble is that the risk-benefit ratio of developing autoimmune diseases after vaccination for HPV has not yet been resolved.

Remember Dr. Yehuda Shoenfeld’s words, ”If the negative effects outweigh the benefits, the vaccine should not be prescribed.”

Merck’s own prescribing information sheet states for every 100,000 people who use Gardasil 2,500 serious adverse events are to be expected.

According to the FDA a serious adverse event must fit one of the following criteria: death, life-threatening, hospitalization, disability or permanent damage, congenital abnormality/birth defect, or the requirement to intervene to prevent permanent impairment.

No Country in the World has a cervical cancer diagnosis rate of 2500 /100,000

As a matter of fact, Malawi currently has the highest cervical cancer diagnosis rate in the world at 75.9/100,000. No one in their right mind would trade that number for 2,500 serious adverse events per 100,000 vaccine recipients.

When it comes to HPV vaccines, the risks obviously do NOT outweigh the benefits.

The time has come to halt all HPV vaccination programs until the safety issues have been resolved and efficacy has been scientifically proven.

Stop sacrificing our children on the altar of The Greater Good!

Money and profit should NEVER trump children’s health!

Sources:

This article in it’s entirety, is compliments of www.SaneVax.org

HPV vaccine controversy in Colombia continues#cdcwhistleblower#Columbia#HPV

January 13, 2015January 12, 2015 jv Leave a comment

By Norma Erickson

Carmen de Bolivar, Colombia has become ground zero in the international debate over HPV vaccine safety, efficacy, and need. After the administration of the 2nd dose of Gardasil in local schools, beginning in March 2014, hundreds of young girls were admitted to the hospital with mysterious new medical conditions.

According to local sources, doctors who examined the girls and reported symptoms as possible adverse reactions to the HPV vaccine would often find manufacturer’s representatives in their office the next day trying to convince them otherwise.

The National Ministry of Health (Minsalud) initially put forth several theories to explain the symptoms of over 700 girls including mass hysteria, illicit drug use, and even the excessive use of Ouija boards. They even went so far as to enlist the services of Nobel Prize nominee, Dr. Nubia Muñoz Calero, to help ease the tension. (read more here.) Her message was basically that it would be a mistake to halt the current school-based HPV vaccination programs in Colombia.

Apparently parents of those affected, many doctors who personally examined the girls, at least one judge, and Inspector General Alejandro Ordoñez do not necessarily agree.

Inspector General responds to Gardasil injury controversy

According to a December 5, 2014 report on Caracol Radio, Inspector General Alejandro Ordoñez issued a circular addressed to the Ministry of Health and Social Protection, the National Institute of Health, and several other organizations asking that priority be given to ensuring the right to health of those with new medical conditions after Gardasil. He also requested further monitoring and timely comprehensive treatment to girls who were apparently affected by the HPV vaccine.

In addition, he asked the National Institute of Health and other responsible parties to disclose the technical and scientific studies relating to HPV vaccine safety and approval for use in Colombia along with all details regarding the guidelines for the management of Gardasil doses from manufacture through administration.

He also asked for plans to develop plans to implement and strengthen the epidemiological reporting of cases of suspected adverse reactions as well as plans to review and upgrade the rules ensuring rigor in the process of vaccine approvals and to establish communication strategies to make certain health policies in Colombia are developed and implemented in a manner guaranteed to ensure the public’s right to health, control of preventable diseases, and welfare of the entire population.

Judicial system protects those with new medical conditions after Gardasil

15 December 2014: Attorney Monica Leon Del Rio, representing several Colombian girls experiencing new medical conditions after the administration of Gardasil, reported that Honorable Magistrate Dr. Hirina Meza issued a provisional decree in favor of ten girls from Carmen de Bolivar.

This decree orders EPPS-S Mutual, the Secretary of Health in the municipality of Carmen de Bolivar, the Secretary of Health Bolivar Department, and the Ministry of Health to imediately organize complementary and coordinated actions necessary to effectively dispense to the child plaintiffs treatments integral to those who are disabled guaranteeing the supply of medicines, procedures and services, including any and all required treatments regardless of whether or not the costs incurred are covered in the patient’s current health insurance program or the Public Health Plan (POS).

The Honorable Magistrate also ordered Dr. Juan Manuel Anaya, immunologist and Director of the Center for the Study of Autoimmune Diseases, to examine the plaintiffs and report on the following aspects of their cases:

Any relationship between the plaintiffs’ current disability and the administration of Human Papillomavirus vaccine, pointing out whether or not evidence of a causal relationship exists;
Any medications that exhibit similar consequences which may have been administered to the plaintiffs;
Any other potential causes of the disabilities currently exhibited by the plaintiffs;
And to inform the Court of everything in relation to the issues above and/or pertinent to the order of protection being issued by the Court.

This decision in favor of 10 young Colombian girls suffering mysterious new medical conditions after the administration of Gardasil comes a few short weeks after a similar landmark decision issued in favor of a survivor of Gardasil and her newborn daughter, also represented by Attorney Monica Leon Del Rio. on 14 November 2014. (Read more here.)

National Institute of Health adds insult to injuries

According to a January 6, 2015 report on Elheraldo.co, parents of injured girls in Carmen de Bolivar were outraged when the Colombian National Institute of Health (INS) ’leaked’ the final report on their ’scientific investigation’ into the epidemic of new medical conditions occurring after the administration of the second dose of Gardasil.

According to this ’leaked’ report none of the symptoms experienced by the girls are related to the administration of Gardasil. This report specifically stated the children did not have ’organic disorders’ or neurological diagnosis, or other diagnosed conditions so obviously they do not suffer from any physical illness.

The institute stated all doses applied in Carmen de Bolivar were from the same manufacturer, the same batch and that all cold chain transportation requirements were followed, so nothing could have affected the vaccine composition.

After many lengthy explanations, the report came to the conclusion the cases are due to ’episodes of psychogenic cause,’ due to the minor’s fear of being sick, augmented by the media attention on the events and lack of an identified cause.

According to Attorney Monica Leon Del Rio, this ’conclusion’ ignores evidence presented at a December 11 meeting presided over by Health Minister Alejandro Gaviria where Immunologist, Dr. Anaya, presented evidence of a causal relationship between the symptoms of 3 girls and the administration of Gardasil. She questions why Health Minister Gaviria did not order the National Institutes of Health to perform tests similar to those done by Dr. Anaya when establishing the possibility of demyelinating disorders being linked to Gardasil administration.

Why did Minister Gaviria allow the INS to simply examine paperwork, look for other causes, ignore Gardasil as a possible link and issue the conclusion of ’mass hysteria/psychogenic illness’?

Parents of HPV vaccine survivors outraged

More than 700 young girls suffered new medical conditions in Carmen de Bolivar after the administration of Gardasil. Their parents are outraged by the report issued by NIH.

Professor Hector Miranda, leader of one of the two parent’s associations created to defend their children’s fundamental right to life and health, stated,

“This was not the Ouija board, nor witchcraft, or pudding pot, or polluted water, everything is for the vaccine, that is proven with other girls from other parts of the world who suffered the same symptomatology”

Monica Leon Del Rio is no stranger to the HPV vaccine controversy. She is the mother of a young woman who experienced paralysis and various medical dysfunctions after the administration of HPV vaccine in January 2013. She is currently representing at least 50 other girls from El Carmen de Bolivar who are exhibiting new medical conditions after using HPV vaccines. Her mission is to ensure survivors of HPV vaccinations receive proper medical diagnosis and treatment.

According to a report in Colombia Reports, Inspector General Alejandro Ordoñez is a polarizing figure in Colombia. He has risen through the ranks of Colombian politics to a position of great power, all the while guided by an unyielding moral vision that has made him a righteous crusader to some; a dangerous zealot to many others.

Perhaps Inspector General Alejandro Ordoñez and Attorney Monica Leon Del Rio are just what the parents of Carmen de Bolivar need to obtain justice for their children.

Read or print this article in Spanish here.

The SaneVax team would like to thank Alicia Capillia (AAVP) and Mario Lamo for kindly providing the translation of this document. Your hard work and dedication is greatly appreciated.

This article in it’s entirety is compliments of www.SaneVax.org

HPV Vaccines: SaneVax Message to Colombia#Family#Columbia#HPV

December 22, 2014December 19, 2014 jv Leave a comment

By Norma Erickson

Attorney Monica Leon Del Rio is currently representing several Colombian girls who are experiencing new medical conditions after the administration of Gardasil. She recently invited me to speak to a group of esteemed public health officials, government representatives and medical people in Colombia to explain why the SaneVax team does not support HPV vaccination programs.Just prior to the time I was to address the meeting, the international conference call was disconnected. Despite multiple attempts to re-establish the connection I was not able to speak as scheduled.

Therefore, my intended message to Colombia is as follows:

SaneVax is an international non-profit organization working with representatives in over 25 countries, all of whom are concerned about HPV vaccines. The SaneVax team believes vaccines should meet four common sense criteria prior to their inclusion in mass vaccination programs. We believe they should be scientifically proven safe, affordable, necessary and effective prior to government approval.

The SaneVax Team cannot support HPV vaccination programs for many reasons.

#1 HPV VACCINES ARE NOT PROVEN SAFE

There are over 80 vaccines approved for use in the United States. HPV vaccines account for nearly 25% of the entire Vaccine Adverse Event Reporting System (VAERS) database. This is particularly disturbing because the VAERS system was established in 1990 and HPV vaccines were not introduced until mid-2006.
VAERS reports of ADEM have increased over 1,000% since the introduction of HPV vaccines; infertility reports increased 790%, reports of blindness increased 188%, and spontaneous abortions by 270%.
According to documents submitted to the Supreme Court in India, when 24,000 girls were injected with HPV vaccines during ‘demonstration projects’ an estimated 5% (1200) were left with chronic health problems and/or autoimmune disorders.
Japan withdrew the government recommendation for the administration of HPV vaccines after only 6 weeks when reports of adverse events after Gardasil were 26 times higher than the annual flu shot; reports after Cervarix were 52 times higher than the annual flu shot. 24.9% of the adverse events reported were considered serious.
Denmark reports that 24% of the adverse events reported after HPV vaccinations were considered serious.
Italy reports adverse events after HPV vaccines at a rate of 219/100,000 – ten times higher than most other vaccines administered in Italy. The cervical cancer rate in Italy is 7.7/100,000.

#2 HPV VACCINES ARE NOT AFFORDABLE

HPV vaccination programs do not eliminate the need for pap screening, they simply add the price of 3 injections to already overburdened healthcare systems around the globe.
There is an already proven safe and effective method of controlling cervical cancer in most developed countries – pap screening and good gynecological follow-up. Countries without this practice in place would be money ahead to spend their healthcare budget developing the infrastructure to provide this type of care.
Cervical cancer causes 2.3 deaths/100,000 women in the United States. The cost of 3 doses of HPV vaccine for 100,000 women is an estimated $30,000,000 ($100/dose) to try and eliminate less than 3 deaths which could have been avoided with pap screening and good gynecological follow-up. How many medical professionals could be trained and/or medical facilities built with that same 30 million dollars?

#3 HPV VACCINES ARE NOT NECESSARY

The human papillomavirus has never been proven to cause cancer by itself. Other risk factors must also be present in order to prompt the development of cancer.
According to the World Health Organization, only 0.15% of all people exposed to any high-risk strain of HPV will ever develop cervical cancer. The vast majority of HPV ‘infections’ are benign and cause no medical problem whatsoever.
HPV type prevalence varies greatly from one region to the next. Are the HPV types targeted by current vaccines the same ones prevalent in your country?
There is no excuse for exposing the female population of the world to the risks involved with HPV vaccination when there is an already proven safe, affordable, necessary and effective means of controlling cervical cancer.

#4 HPV VACCINES ARE NOT PROVEN EFFECTIVE

According to the World Health Organization, only 1% of CIN1 progresses to the next stage, only 1.5% of CIN2 progresses. Only 12% of CIN3 lesions, which are actually considered a pre-cursor to cancer. Nevertheless, the FDA allowed the manufacturers of HPV vaccines to use these often self-reversing abnormal lesions as endpoints to judge the efficacy of their products.
The other endpoint used to predict efficacy was antibody titers. No one has determined what level of antibodies is necessary to prevent HPV infections. It is simply assumed that the higher the antibody titer level, the better the potential protection.
HPV vaccines have not been clinically proven to prevent a single case of cancer.
There is no guarantee that eliminating one risk factor for the development of cervical cancer will have any impact on the disease incidence or mortality rate.
It will take more than 20 years to determine whether or not HPV vaccines perform as advertised.
There is no guarantee that any suppressed oncogenic HPV type will not mutate over the next 20 years and become more dangerous.

I would respectfully submit that all of these facts should be taken into consideration when evaluating the HPV vaccination program in Colombia.

Please consider every new medical condition following HPV vaccine administration to be a potential adverse event. Thorough investigations are the only way to determine the safety profile of HPV vaccines in your country.

Please take action to protect your future generation.

Halt the current HPV vaccination program until you have determined whether or not HPV vaccines are a good addition to your cervical cancer prevention program.

You must answer the question – Are HPV vaccines Safe, Affordable, Necessary and Effective in Colombia?

a abogada Mónica León Del Rio actualmente representa a varias niñas colombianas que están experimentando nuevas afecciones médicas después de la administración de Gardasil. Ella hace poco me invitó a hablar a un grupo de funcionarios de salud pública, representantes gubernamentales y personal médico en Colombia para explicar por qué el equipo SaneVax no respalda los programas de vacunación contra el VPH.Justo antes de mi participación en la conferencia internacional, se desconectó la llamada. A pesar de múltiples intentos para restablecer la conexión no pude hacer mi presentación.

Por lo tanto, mi mensaje destinado a Colombia es el siguiente:

SaneVax es una organización internacional sin ánimo de lucro que trabaja con representantes en más de 25 países, todos los cuales están preocupados acerca de las vacunas contra el VPH. El equipo SaneVax cree que las vacunas deben cumplir con 4 criterios de sentido común antes de incluirse en los programas de vacunación masiva. Creemos que deben ser demostrados científicamente que son seguras, asequibles, necesarias y eficaces antes de ser aprobadas por el gobierno.

El Equipo SaneVax no puede apoyar los programas de vacunación contra el VPH por muchas razones.

#1 No se ha demostrado que las vacunas contra el VPH sean SEGURAS

Hay más de 80 vacunas aprobadas para su uso en los Estados Unidos. Las vacunas contra el VPH representan casi el 25% de toda la base de datos de Eventos Adversos de Vacunas (VAERS). Esto es especialmente preocupante porque el sistema VAERS se estableció en 1990 y vacunas contra el VPH no se introdujeron hasta mediados de 2006.
VAERS informa que los casos de Encefalitis Aguda Diseminada se han incrementado en un 1.000% desde la introducción de vacunas contra el VPH; los informes de infertilidad se incrementaron 790%, los casos de ceguera aumentaron 188%, y los abortos espontáneos por 270%.
De acuerdo con los documentos presentados a la Corte Suprema de la India, cuando 24.000 niñas fueron inyectadas con vacunas contra el VPH durante los “proyectos de demostración”, se estima que un 5% (1.200) quedaron con problemas de salud crónicos y / o trastornos autoinmunes.
Japón retiró la recomendación del gobierno para la administración de las vacunas contra el VPH después de sólo 6 semanas, cuando los informes de eventos adversos después de la aplicación del Gardasil eran 26 veces más altos que los de la vacuna anual contra la gripe; los informes de eventos adversos después de la aplicación de Cervarix fueron 52 veces más altos que los de la vacuna anual contra la gripe. El 24,9% de los eventos adversos informados fueron considerados graves.
Dinamarca informa que se consideran graves un 24% de los eventos adversos informados después de la vacunación contra el VPH.
Italia informa de los eventos adversos después de la aplicación de las vacunas contra el VPH a una tasa del 219/100 000 – diez veces más alta que la mayoría de las vacunas administradas en Italia. La tasa de cáncer de cuello uterino en Italia es de 7,7 / 100.000.

#2 Las vacunas contra el VPH NO SON ADSEQUIBLES

Los programas de vacunación contra el VPH no eliminan la necesidad de las pruebas de detección de Papanicolaou (citología vaginal), inclusive hay que añadir el precio de 3 inyecciones que se sobrecargan a los sistemas sanitarios de todo el mundo.
La detección mediante la prueba de citología vagina (prueba de Papanicolaou) es un método seguro y eficaz ya probado para controlar el cáncer cervical en los países más desarrollados incluyendo el buen seguimiento ginecológico.
El cáncer cervical provoca 2,3 muertes / 100.000 mujeres en los Estados Unidos. El costo de 3 dosis de la vacuna contra el VPH para 100.000 mujeres tiene un costo estimado de $ 30.000.000 ($ 100 / dosis) para tratar de eliminar menos de 3 muertes que podrían haberse evitado con la prueba de Papanicolaou y un buen seguimiento ginecológico. ¿Cuántos profesionales de la medicina podrían ser capacitados o cuántas instalaciones médicas se podrían construir con los mismos 30 millones de dólares?

#3 Las vacunas contra el VPH no son necesarias

El virus del papiloma humano nunca se ha demostrado que cause el cáncer por sí mismo. Otros factores de riesgo también deben estar presentes para facilitar el desarrollo del cáncer.
De acuerdo con la Organización Mundial de la Salud, sólo el 0,15% de todas las personas expuestas a cualquier cepa de alto riesgo de VPH desarrollarán cáncer cervical. La gran mayoría de los ”infecciones” por VPH son benignas y no causan ningún problema médico.
La prevalencia del tipo de VPH varía mucho de una región a otra. ¿Son los tipos de VPH que son el blanco de las vacunas actuales los mismos que prevalecen en su país?
No hay excusa para la exposición de la población femenina del mundo a los riesgos que implica la vacunación contra el VPH cuando ya hay métodos seguros, asequibles, necesarios y efectivos probados para el control del cáncer cervical.

#4 Las vacunas contra el VPH no tienen una eficacia demostrada

De acuerdo con la Organización Mundial de la Salud, sólo el 1% de Neoplasia Intraepitelial Cervical 1 (CIN1) avanza a la siguiente etapa CIN2 y de esta sólo el 1,5% progresa. Solo un 12% de las lesiones CIN3 son en verdad consideradas como precursoras del cáncer. Sin embargo, la FDA permitió a los fabricantes de vacunas contra el VPH utilizar estas lesiones anormales que a menudo se curan por sí mismas como criterios para juzgar la eficacia de la vacuna.
El otro criterio de valoración utilizado para predecir la eficacia fueron las medidas de anticuerpos. Nadie ha determinado cuál es el nivel de anticuerpos necesario para prevenir las infecciones por VPH. Simplemente se supone que el nivel más alto de anticuerpos es potencialmente mejor.
No se ha demostrado clínicamente que ninguna vacuna contra el VPH prevenga un solo caso de cáncer.
No hay garantía de que la eliminación de un factor de riesgo para el desarrollo de cáncer de cuello uterino (infección por VPH) tendrá impactos sobre la incidencia de la enfermedad o tasa de mortalidad.
Tardará más de 20 años para determinarse si las vacunas contra el VPH funcionan o no como se anuncia.
No hay garantía de que cualquier tipo de VPH oncogénico suprimido por la vacuna no va a mutar en los próximos 20 años y ser más peligroso.

Me permito pedir respetuosamente que todos estos hechos sean tenidos en cuenta al evaluar el programa de vacunación contra el VPH en Colombia.

Por favor consideren que cada nuevo caso de anormalidad médica luego de la administración de la vacuna contra el VPH puede ser un evento adverso a la misma. Las investigaciones exhaustivas son la única manera de determinar el perfil de seguridad de las vacunas contra el VPH en su país.

Por favor, tomen medidas para proteger sus generaciones futuras.

Detengan el programa de vacunación contra el VPH actual hasta que se haya determinado si las vacunas contra el VPH son una buena adición al programa de prevención de cáncer de cuello uterino.

Deben responder a la pregunta – ¿Son las vacunas contra el VPH seguras, asequibles, necesarias y eficaces en Colombia?

This article in it’s entirety, is compliments of www.SaneVax.org

HPV Vaccination Program in Colombia: Undermining the Truth?#Family#Vaccines#Columbia

November 28, 2014November 25, 2014 jv Leave a comment

By Norma Erickson

Hundreds of young women in Carmen de Bolivar, Colombia ended up in hospitals since the administration of the second dose of Gardasil beginning in schools on March 20, 2014. Local newspapers report as many as 700 girls being sent to emergency rooms after receiving Gardasil over the last few months.

According to a local school teacher:

The girls in Carmen de Bolivar received their first dose of Gardasil in July 2013, after which reported reactions were similar to other vaccines (redness, swelling, pain at the injection site, etc…). The second dose was administered on the 20^th of March 2014. Several girls reacted immediately and much more severely, reporting dizziness, syncope, and severe headaches. By May 29th to the 30^th, the situation had turned into a full-blown crisis with scores of girls being admitted to local emergency room facilities to be treated for fainting, shortness of breath, weakness in the limbs etc…

No one seems to know what instigated this epidemic number of hospital visits. Government health officials emphatically denied that Gardasil could be causing the extraordinary number of new medical conditions. Instead, they put forth theories such as lead poisoning, mass hysteria and even too much Ouija board use.

Parents of the affected girls did not agree with any of these theories. They knew the only thing that had recently changed in their daughters’ life was the administration of the second dose of the HPV vaccine, Gardasil.

Hundreds of parents took to the streets in peaceful demonstrations to demand investigations; others burned tires in protest, blocking a main road connecting a coastal town with the interior. For the first time in the history of Colombia, perhaps the world, parents launched massive public protests over the administration of a vaccine that is apparently making people sick instead of protecting them. (read more)

Parents of affected children suspected Health Minister Alejandro Gaviria of being less than truthful, being misinformed, or simply protecting special interest groups supporting the use of Gardasil and they were not shy about stating their suspicions in any public forum they could gain access to.

Health Minister Gaviria accused media representatives of contributing to the creation of an epidemic of ’mass hysteria’ and publicly requested journalists and media personnel to exercise ’more responsible journalism.’

Enter Nobel-prize nominee, Dr. Nubia Muñoz Calero

Sunday, October 5, 2014, Alda Mera, reporter for El Pais, published an article titled, The HPV vaccine saves lives, Nubia Muñoz Calero. Reporter Alda Mera apparently thought there was no one better to allay the fears of Colombian parents than an epidemiologist who had been born, raised and educated in Colombia, who had participated in cancer research for more than 30 years and been nominated to receive a Nobel Prize for her work. This medical scientist was Dr. Nubia Muñoz Calero. (read her biography here)

Unfortunately, the article published as a result of reporter Alda Mera’s interview with Dr. Nubia Muñoz Calero continues to market HPV vaccines via fear, not facts.

Please examine the statements from Alda’s article below when compared with documented factual information:

According to Dr. Muñoz Calero, when asked if Colombia understands the importance of her discovery that HPV causes cervical cancer, the good doctor states, ”I am not the inventor of (HPV) vaccines, pharmaceutical companies developed them. I have no commercial interest in them.”

FACT: What Dr. Muñoz Calero fails to mention is that she is a member of the Merck HPV Global Advisory Board. This may not be what one would technically call a commercial interest. However, it does constitute a substantial conflict of interest when one is being portrayed as an independent scientific expert. (verify here) Why did Reporter Alda Mera not disclose this information?

According to Dr. Muñoz Calero, her contribution was to demonstrate with well-planned epidemiological studies that the human papillomavirus is the main and necessary cause of cervical cancer.

FACT: Epidemiological studies never prove causation. They cannot prove that a specific risk factor actually causes the disease being studied. Epidemiological evidence can only show that this risk factor is associated (correlated) with a higher incidence of disease in the population exposed to that risk factor. The higher the correlation the more certain the association, but an epidemiological study cannot prove causation. (verify here)

It is also important to note that papers published prior to FDA approval of Gardasil refer to HPV as being ’associated with’ the development of cervical cancer. It was only after FDA approval of Gardasil that ’scientific’ papers began to refer to human papillomavirus as being ’causally associated’ with the development of cervical cancer. This phrase soon morphed into HPV being ’the main and necessary cause’ of cervical cancer. (verify here, in Dr. Muñoz Calero’s own published paper – simply scroll through the referenced papers and look at their dates of publication.)

According to Dr. Muñoz Calero, she had helped identify the two types of HPV (human papillomavirus) responsible for 70% of cervical cancer.

FACT: What the esteemed doctor failed to mention is the fact that the two types identified may not be the prevalent types in the Colombian population. If HPV 16/18 are not the prevalent types in Colombian women, any effect Gardasil may have on the prevalence of cervical cancer in her country would diminish substantially. (verify here)

According to Dr. Muñoz Calero, when asked about the safety demonstrated during the clinical trials of Gardasil, she stated, ”As an intramuscular injection (Gardasil) produces some pain in 80% of girls, heat and redness in the arm. A small percentage have headaches and fevers, 10% for maybe one or two days. But these 40,000 women (who participated in clinical trials) did not suffer syncope, fainting, or diseases that (are) now blamed on the vaccine.

FACT: According to documentation presented to the FDA prior to Gardasil approval in the United States, 73.3% of clinical trial participants who received Gardasil reported new medical conditions after vaccine administration. It is interesting to note that 76.3% of those who received the so-called ’placebo’ also reported new medical conditions after injection. The problem here is that the ’placebo’ used was not an inert substance – it consisted of the brand new (not safety tested) proprietary aluminum adjuvant Merck developed for use in Gardasil and a ’carrier’ solution with undisclosed ingredients. The only thing these clinical trials proved was that Gardasil was no less dangerous than the adjuvant used in Gardasil. Many of the new medical conditions reported during clinical trials are the same ones being reported around the world after Gardasil administration. (verify here) (list of reported new medical conditions from clinical trials here)

According to Dr. Muñoz Calero, when asked whether Gardasil had been rushed to market, stated that the laboratories created the first human papillomavirus vaccine at the end of the 90’s, and began phase I and II clinical trials before 2000.

FACT: Merck’s development program for the HPV quadrivalent vaccine for prevention of cervical cancer was granted fast track designation in 2002. Merck initiated phase 3 clinical trials of the HPV quadrivalent vaccine in 2002. (verify here) This fast track designation was granted despite the fact that Merck’s proposed vaccine did not meet any of the criteria required for fast track approval. (verify here)

According to Dr. Muñoz Calero, when asked about the adverse reactions being reported in Colombia, says she does not know in detail what is happening in Carmen de Bolivar because she does not live in the country; but based on what she’s read and been told by colleagues….200,000 million doses have been distributed (not necessarily administered) in the world. WHO, PAHO, FDA and EMA say that Gardasil is safe and there is no scientific evidence showing (that it) triggers autoimmune diseases (Guillán-Barre syndrome, multiple sclerosis, transverse myelitis).

FACT: There may be no concrete scientific proof that HPV vaccines are triggering and/or causing the adverse events being reported in every country where they are administered. However, there is also no scientific proof that HPV vaccines are NOT causing these new medical conditions either. There is no such thing as an epidemic of coincidence.

The SaneVax team would like Dr. Muñoz Calero to explain why biologically plausible mechanisms of action that could explain new medical conditions occurring after the administration of HPV vaccines presented by scientists and medical researchers around the globe is not being investigated thoroughly by any of the alphabet organizations she mentions which all have vested interests in mass administration of one of the most expensive vaccines ever produced. (verify here and here)

Near the end of the interview, Dr. Muñoz Calero is asked if it would be a good idea to stop mass HPV vaccinations in Colombia until after investigations to determine which children are at risk for adverse reactions. She states:

No. It would be a mistake to stop the program. Countries that achieve the highest coverage are those with school-based programs. What I recommend is to increase education programs for physicians, media, and communities. Make them understand that this vaccine is the best weapon against cervical cancer.

Dr. Muñoz Calero, since when is it a mistake to apply the precautionary principle to the administration of a medical intervention of any kind?

Anyone with an ounce of compassion would be fighting to protect the continued health and well-being of the young girls in their native land; NOT fighting to preserve the uptake of a vaccine which might be responsible for epidemic numbers of health problems.

The new medical conditions occurring after Gardasil administration must be investigated thoroughly before any more young women are subjected to devastating potential risks in exchange for the highly debatable promise of a reward 20 years down the road.

The latest ’medical miracle’ can wait until after independent investigations determine it to be safe.

By the way, there is a huge difference between being ’anti-vaccine’ and supporting vaccine safety.

If a pharmaceutical company cannot market their products based on facts, they should not be allowed to market them at all!

This article in it’s entirety, is compliments of www.SaneVax.org